Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  PubMed  Google Scholar 

Wei J, Wu ND, Liu BR. Regional but fatal: intraperitoneal metastasis in gastric cancer. World J Gastroenterol. 2016;22(33):7478–85. https://doi.org/10.3748/wjg.v22.i33.7478.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Dijksterhuis WPM, Kroese TE, Verhoeven RHA, van Rossum PSN, Mook S, Haj Mohammad N, et al. A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases. Eur J Surg Oncol. 2022. https://doi.org/10.1016/j.ejso.2022.03.003.

Article  PubMed  Google Scholar 

Riihimaki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget. 2016;7(32):52307–16. https://doi.org/10.18632/oncotarget.10740.

Article  PubMed  PubMed Central  Google Scholar 

Shin CH, Lee WY, Hong SW, Chang YG. Characteristics of gastric cancer recurrence five or more years after curative gastrectomy. Chin J Cancer Res. 2016;28(5):503–10. https://doi.org/10.21147/j.issn.1000-9604.2016.05.05.

Article  PubMed  PubMed Central  Google Scholar 

Kano Y, Ohashi M, Muneoka Y, Takahari D, Chin K, Yamaguchi K, et al. Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy. Eur J Surg Oncol. 2021;47(12):3097–104. https://doi.org/10.1016/j.ejso.2021.04.018.

Article  PubMed  Google Scholar 

Xu J, Shen L, Shui Y, Yu W, Guo Q, Yu R, et al. Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy. Cancer Med. 2020;9(13):4724–35. https://doi.org/10.1002/cam4.3085.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides GA, Fields RC, et al. Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis. J Am Coll Surg. 2014;219(4):664–75. https://doi.org/10.1016/j.jamcollsurg.2014.03.062.

Article  PubMed  Google Scholar 

Sirody J, Kaji AH, Hari DM, Chen KT. Patterns of gastric cancer metastasis in the United States. Am J Surg. 2022. https://doi.org/10.1016/j.amjsurg.2022.01.024.

Article  PubMed  Google Scholar 

Lu Y, Jin Z, Zheng S, Bai Y, Sun Y. Hyperthermic intraperitoneal chemotherapy combined with systemic chemotherapy for gastric cancer peritoneal carcinomatosis: a protocol for systematic review and meta-analysis of randomized controlled trials. Medicine. 2020;99(27): e20973. https://doi.org/10.1097/MD.0000000000020973.

Article  PubMed  PubMed Central  Google Scholar 

Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer. 1999;85(3):529–34.

CAS  Article  Google Scholar 

Jayne D. Molecular biology of peritoneal carcinomatosis. Cancer Treat Res. 2007;134:21–33. https://doi.org/10.1007/978-0-387-48993-3_2.

CAS  Article  PubMed  Google Scholar 

Cabourne EJ, Roberts G, Goldin R, Ryder T, Mobberly M, Ziprin P. Investigation of tumor-peritoneal interactions in the pathogenesis of peritoneal metastases using a novel ex vivo peritoneal model. J Surg Res. 2010;164(2):e265–72. https://doi.org/10.1016/j.jss.2010.09.041.

CAS  Article  PubMed  Google Scholar 

Zheng LN, Wen F, Xu P, Zhang S. Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: a systemic review and meta-analysis. World J Clin Cases. 2019;7(20):3247–58. https://doi.org/10.12998/wjcc.v7.i20.3247.

Article  PubMed  PubMed Central  Google Scholar 

Maeda H, Kobayashi M, Sakamoto J. Evaluation and treatment of malignant ascites secondary to gastric cancer. World J Gastroenterol. 2015;21(39):10936–47. https://doi.org/10.3748/wjg.v21.i39.10936.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lim B, Kim C, Kim JH, Kwon WS, Lee WS, Kim JM, et al. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites. Oncotarget. 2016;7(7):8055–66. https://doi.org/10.18632/oncotarget.6977.

Article  PubMed  PubMed Central  Google Scholar 

Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol. 2007;18(5):945–9. https://doi.org/10.1093/annonc/mdl499.

CAS  Article  PubMed  Google Scholar 

Lv ZD, Na D, Liu FN, Du ZM, Sun Z, Li Z, et al. Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis. J Exp Clin Cancer Res. 2010;29:139. https://doi.org/10.1186/1756-9966-29-139.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Montori G, Coccolini F, Ceresoli M, Catena F, Colaianni N, Poletti E, et al. The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art. Int J Surg Oncol. 2014;2014:912418. https://doi.org/10.1155/2014/912418.

Article  PubMed  PubMed Central  Google Scholar 

Tan HL, Chia CS, Tan GH, Choo SP, Tai DW, Chua CW, et al. Gastric peritoneal carcinomatosis—a retrospective review. World J Gastrointest Oncol. 2017;9(3):121–8. https://doi.org/10.4251/wjgo.v9.i3.121.

Article  PubMed  PubMed Central  Google Scholar 

Saif MW, Siddiqui IA, Sohail MA. Management of ascites due to gastrointestinal malignancy. Ann Saudi Med. 2009;29(5):369–77. https://doi.org/10.4103/0256-4947.55167.

Article  PubMed  PubMed Central  Google Scholar 

Matte I, Lane D, Laplante C, Rancourt C, Piche A. Profiling of cytokines in human epithelial ovarian cancer ascites. Am J Cancer Res. 2012;2(5):566–80.

CAS  PubMed  PubMed Central  Google Scholar 

Sangisetty SL, Miner TJ. Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012;4(4):87–95. https://doi.org/10.4240/wjgs.v4.i4.87.

Article  PubMed  PubMed Central  Google Scholar 

Kim S, Kim B, Song YS. Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer. Cancer Sci. 2016;107(9):1173–8. https://doi.org/10.1111/cas.12987.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Mikula-Pietrasik J, Uruski P, Szubert S, Moszynski R, Szpurek D, Sajdak S, et al. Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors. Med Oncol. 2016;33(8):94. https://doi.org/10.1007/s12032-016-0810-4.

CAS  Article  PubMed  Google Scholar 

Aslam N, Marino CR. Malignant ascites: new concepts in pathophysiology, diagnosis, and management. Arch Intern Med. 2001;161(22):2733–7. https://doi.org/10.1001/archinte.161.22.2733.

CAS  Article  PubMed  Google Scholar 

Ahmed N, Stenvers KL. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol. 2013;3:256. https://doi.org/10.3389/fonc.2013.00256.

Article  PubMed  PubMed Central  Google Scholar 

Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13(4):273–82. https://doi.org/10.1038/nrc3432.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Bae GE, Kim SH, Choi MK, Kim JM, Yeo MK. Targeted sequencing of ascites and peritoneal washing fluid of patients with gastrointestinal cancers and their clinical applications and limitations. Front Oncol. 2021;11:712754. https://doi.org/10.3389/fonc.2021.712754.

Article  PubMed  PubMed Central  Google Scholar 

Asem M, Young A, Oyama C, ClaureDeLaZerda A, Liu Y, Ravosa MJ, et al. Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer. Sci Rep. 2020;10(1):11913. https://doi.org/10.1038/s41598-020-68639-2.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Idorn M, Olsen M, Halldorsdottir HR, Skadborg SK, Pedersen M, Hogdall C, et al. Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction. Oncoimmunology. 2018;7(4):e1412029. https://doi.org/10.1080/2162402X.2017.1412029.

Article  PubMed  Google Scholar 

Thibault B, Castells M, Delord JP, Couderc B. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. Cancer Metastasis Rev. 2014;33(1):17–39. https://doi.org/10.1007/s10555-013-9456-2.

CAS  Article  PubMed  Google Scholar 

Marrugal A, Ojeda L, Paz-Ares L, Molina-Pinelo S, Ferrer I. Proteomic-based approaches for the study of cytokines in lung cancer. Dis Markers. 2016;2016:2138627. https://doi.org/10.1155/2016/2138627.

Article  PubMed  PubMed Central  Google Scholar 

Marrugal A, Ojeda L, Paz-Ares L, Molina-Pinelo S, Ferrer I. Corrigendum to “proteomic-based approaches for the study of cytokines in lung cancer.” Dis Markers. 2018;2018:1404780. https://doi.org/10.1155/2018/1404780.

Article  PubMed  PubMed Central  Google Scholar 

Penson RT, Kronish K, Duan Z, Feller AJ, Stark P, Cook SE, et al. Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int J Gynecol Cancer. 2000;10(1):33–41. https://doi.org/10.1046/j.1525-1438.2000.00003.x.

Article  PubMed  Google Scholar